Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug 18.
doi: 10.1007/s10067-025-07634-2. Online ahead of print.

Clinical value of biomarkers in relation to artery size in eosinophilic granulomatosis with polyangiitis: findings from an inception cohort at a Japanese City Hospital

Hiroshi Oiwa  1 , Akihiro Yahata  2 , Naoki Nakamoto  2
Affiliations

Clinical value of biomarkers in relation to artery size in eosinophilic granulomatosis with polyangiitis: findings from an inception cohort at a Japanese City Hospital

Hiroshi Oiwa et al. Clin Rheumatol. .

Abstract

Introduction/objectives: Eosinophilic granulomatosis with polyangiitis (EGPA) is a necrotizing vasculitis that frequently affects small arteries in the skin and the nerve but can also involve the medium-sized arteries, resembling polyarteritis nodosa (PAN). This study aimed to evaluate the clinical value of biomarkers in EGPA in relation to the size of the affected arteries.

Method: In an inception cohort of EGPA, we examined the relationships between eosinophil counts, myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) positivity, levels of rheumatoid factor (RF) and Immunoglobulin E (IgE) and pre-defined outcomes based on artery size. These outcomes included histologically confirmed cutaneous vasculitis, glomerulonephritis, PAN-like arteritis in the cranial and abdominal arteries, and cardiomyopathy.

Results: IgE levels were significantly elevated in patients with cutaneous vasculitis and cardiomyopathy compared to those without the respective conditions. The median IgE values (range) were 3620 IU/mL (1160-6520) vs. 1000 IU/mL (229-5490) for cutaneous vasculitis (p = 0.0077), and 4065 IU/mL (1320-6520) vs. 1205 IU/mL (229-4030) for cardiomyopathy (p = 0.032). A numerically higher frequency of MPO-ANCA was observed in cases with PAN-like arteritis compared to those without (4/5 vs 8/25), similar to the findings for MPO-ANCA in glomerulonephritis. The crude odds ratio of MPO-ANCA positivity for both glomerulonephritis and PAN-like arteritis was 8.50 (95% CI: 1.05-181.45). The optimal IgE thresholds for detecting cutaneous vasculitis and cardiomyopathy were 1860 IU/mL and 2465 IU/mL, respectively, with areas under the curve of 0.82 and 0.84, indicating favorable diagnostic performance.

Conclusions: IgE levels were associated with cutaneous vasculitis and cardiomyopathy in an inception cohort of EGPA in Japan. Further studies with larger cohorts are needed to confirm these findings, as our results are based on a retrospective study with a small sample size. Key Points • IgE levels were associated with cutaneous vasculitis in EGPA. • IgE levels were associated with cardiomyopathy in EGPA. • PAN-like arteritis tended to be associated with MPO-ANCA positivity.

Keywords: Cardiomyopathies; Churg-Strauss Syndrome; Cutaneous vasculitis; Eosinophilic granulomatosis with polyangiitis; Immunoglobulin E; Polyarteritis nodosa.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethical standards: This study complied with the Declaration of Helsinki, and the institutional review board of Hiroshima City Hiroshima Citizens Hospital approved this study (approval no. 2024–122). The need to obtain informed consent from patients was waived in accordance with the regulations for retrospective cohort studies. Information for patients regarding this study was provided on the hospital website. Conflict of interest: HO has received lecture fees from GlaxoSmithKline and AstraZeneca. AY and NN declare no conflicts of interest.

Similar articles

See all similar articles

References

    1. Jennette JC, Falk RJ, Bacon PA et al (2013) 2012 revised international Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum 65:1–11. https://doi.org/10.1002/art.37715 - DOI - PubMed
    1. Oiwa H, Mokuda S, Matsubara T et al (2017) Neurological complications in eosinophilic granulomatosis with polyangiitis (EGPA): the roles of history and physical examinations in the diagnosis of EGPA. Intern Med 56:3003–3008. https://doi.org/10.2169/internalmedicine.8457-16 - DOI - PubMed - PMC
    1. Singh R, Singh D, Abdou N (2009) Churg-Strauss syndrome presenting as acute abdomen: are gastrointestinal manifestations an indicator of poor prognosis? Int J Rheum Dis 12:161–165. https://doi.org/10.1111/j.1756-185X.2009.01399.x - DOI - PubMed
    1. Guillevin L, Lhote F, Gayraud M et al (1996) Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients. Medicine (Baltimore) 75:17–28. https://doi.org/10.1097/00005792-199601000-00003 - DOI - PubMed
    1. Comarmond C, Pagnoux C, Khellaf M et al (2013) Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort. Arthritis Rheum 65:270–281. https://doi.org/10.1002/art.37721 - DOI - PubMed

LinkOut - more resources